My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.

    Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra A.

    J Nanobiotechnology. 2007 Apr 17;5:3.PMID: 17439648 [PubMed]Related articlesFree article

    2.

    Preparation of propolis nanofood and application to human cancer.

    Kim DM, Lee GD, Aum SH, Kim HJ.

    Biol Pharm Bull. 2008 Sep;31(9):1704-10. Retraction in: Kim HJ. Biol Pharm Bull. 2009 Jun;32(6):1135. PMID: 18758063 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.

    Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB.

    Biochem Pharmacol. 2010 Feb 1;79(3):330-8. Epub 2009 Sep 6.PMID: 19735646 [PubMed - indexed for MEDLINE]Related articles

    4.

    Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.

    Mukerjee A, Vishwanatha JK.

    Anticancer Res. 2009 Oct;29(10):3867-75.PMID: 19846921 [PubMed - indexed for MEDLINE]Related articles

    5.

    Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells.

    Sahu A, Bora U, Kasoju N, Goswami P.

    Acta Biomater. 2008 Nov;4(6):1752-61. Epub 2008 May 11.PMID: 18524701 [PubMed - indexed for MEDLINE]Related articles

    6.

    Curcumin as an Anti-Cancer Agent: Review of the Gap between Basic and Clinical Applications.

    Bar-Sela G, Epelbaum R, Schaffer M.

    Curr Med Chem. 2009 Nov 24. [Epub ahead of print]PMID: 19941470 [PubMed - as supplied by publisher]Related articles

    7.

    Curcumin as an Anti-Cancer Agent: Review of the Gap between Basic and Clinical Applications.

    Bar-Sela G, Epelbaum R, Schaffer M.

    Curr Med Chem. 2009 Nov 24;17(3):190-7.PMID: 20214562 [PubMed - in process]Related articles

    8.

    New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.

    Cen L, Hutzen B, Ball S, DeAngelis S, Chen CL, Fuchs JR, Li C, Li PK, Lin J.

    BMC Cancer. 2009 Mar 30;9:99.PMID: 19331692 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification--an in vitro study.

    Kurien BT, Scofield RH.

    J Ethnopharmacol. 2007 Mar 21;110(2):368-73. Epub 2006 Oct 13.PMID: 17116380 [PubMed - indexed for MEDLINE]Related articles

    10.
    11.

    Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.

    Jurenka JS.

    Altern Med Rev. 2009 Jun;14(2):141-53. Review. Erratum in: Altern Med Rev. 2009 Sep;14(3):277. PMID: 19594223 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.

    Mach CM, Mathew L, Mosley SA, Kurzrock R, Smith JA.

    Anticancer Res. 2009 Jun;29(6):1895-9.PMID: 19528445 [PubMed - indexed for MEDLINE]Related articles

    13.

    Solubility of core materials in aqueous polymeric solution effect on microencapsulation of curcumin.

    Aziz HA, Peh KK, Tan YT.

    Drug Dev Ind Pharm. 2007 Nov;33(11):1263-72.PMID: 18058323 [PubMed - indexed for MEDLINE]Related articles

    14.

    Curcumin has bright prospects for the treatment of inflammatory bowel disease.

    Hanai H, Sugimoto K.

    Curr Pharm Des. 2009;15(18):2087-94. Review.PMID: 19519446 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetics and pharmacodynamics of curcumin.

    Sharma RA, Steward WP, Gescher AJ.

    Adv Exp Med Biol. 2007;595:453-70. Review.PMID: 17569224 [PubMed - indexed for MEDLINE]Related articles

    16.

    Curcumin: from ancient medicine to current clinical trials.

    Hatcher H, Planalp R, Cho J, Torti FM, Torti SV.

    Cell Mol Life Sci. 2008 Jun;65(11):1631-52. Review.PMID: 18324353 [PubMed - indexed for MEDLINE]Related articles

    17.

    Immunomodulation by curcumin.

    Gautam SC, Gao X, Dulchavsky S.

    Adv Exp Med Biol. 2007;595:321-41. Review.PMID: 17569218 [PubMed - indexed for MEDLINE]Related articles

    18.

    Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1.

    Li J, Wang Y, Yang C, Wang P, Oelschlager DK, Zheng Y, Tian DA, Grizzle WE, Buchsbaum DJ, Wan M.

    Mol Pharmacol. 2009 Jul;76(1):81-90. Epub 2009 Apr 24.PMID: 19395473 [PubMed - indexed for MEDLINE]Related articles

    19.

    Phase II trial of curcumin in patients with advanced pancreatic cancer.

    Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R.

    Clin Cancer Res. 2008 Jul 15;14(14):4491-9.PMID: 18628464 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Bioavailability of curcumin: problems and promises.

    Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB.

    Mol Pharm. 2007 Nov-Dec;4(6):807-18. Epub 2007 Nov 14. Review.PMID: 17999464 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk